|
|
| (124 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | | | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32143990|t=ä. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32113704|t=2020. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32367343|t=ä. COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection |pdf=|usr=}}
| + | |
| − | {{tp|p=32320516|t=2020. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months |pdf=|usr=}}
| + | |
| − | {{tp|p=32332515|t=2020. Hunting coronavirus severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): From laboratory testing back to basic research |pdf=|usr=}}
| + | |
| − | {{tp|p=32304509|t=2020. Coronavirus disease 2019 in children: Current status |pdf=|usr=}}
| + | |
| − | {{tp|p=32217835|t=ä. Clinical and immunological features of severe and moderate coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32202513|t=ä. Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32244365|t=2020. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence |pdf=|usr=}}
| + | |
| − | {{tp|p=32235486|t=2020. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32110875|t=2020. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | ----
| |
| | | | |
| | + | *'''[[Respiration mgmt]]''' |
| | | | |
| − | *'''[[Structure of covid19]]''' | + | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=32361692|t=2020. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure |pdf=|usr=}}
| + | |
| − | {{tp|p=32306836|t=2020. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Target binding and uptake]]'''
| |
| − | {{tp|p=32344526|t=2020. COVID-19 and RAS: Unravelling an Unclear Relationship |pdf=|usr=}}
| |
| − | {{tp|p=32274964|t=2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | | | |
| − | *'''[[Cytopathic effects]]''' | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| | + | |
| | + | |
| | + | |
| | + | *'''[[Structure of covid19]]''' |
| | + | |
| | + | |
| | + | *'''[[Target binding and uptake]]''' |
| | + | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32360285|t=ä. Type I IFN immunoprofiling in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32344056|t=ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination |pdf=|usr=}}
| |
| − | {{tp|p=32333914|t=ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| − | {{tp|p=32334118|t=ä. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32360286|t=2020. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32311489|t=ä. Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| − | ----
| + | *'''[[Pathobiology]]''' |
| | + | |
| | + | |
| | + | *'''[[Disease Models]]''' |
| | + | |
| | + | |
| | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | + | |
| | + | |
| | | | |
| | | | |
| Zeile 58: |
Zeile 56: |
| | *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| | | | |
| − | *'''[[ARDS]]'''
| |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Hematology]]'''
| |
| | | | |
| − | *'''[[Microvascular]]'''
| |
| | | | |
| − | *'''[[Heart]]'''
| |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| − | {{tp|p=32251791|t=2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 |pdf=|usr=}}
| |
| − | {{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}}
| |
| − | {{tp|p=32332516|t=2020. Precaution and prevention of coronavirus disease 2019 infection in the eye |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Hematology]]''' |
| | | | |
| | | | |
| | | | |
| − | *'''[[Dermatology]]''' | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32243269|t=2020. Gastrointestinal and liver manifestations in patients with COVID-19 |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Kidney, urology]]'''
| |
| | | | |
| − | ----
| + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | | |
| | | | |
| − | *'''[[Pathobiology]]'''}
| |
| | | | |
| | + | *'''[[Dermatology]]''' |
| | | | |
| − | *'''[[Disease Models]]'''
| |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | ----
| |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]''' | + | *'''[[Kidney, urology]]''' |
| − | {{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
| + | |
| − | {{tp|p=32286019|t=2020. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[The morbid survivor]]''' |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32283052|t=ä. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32236303|t=2020. COVID-19 pneumonia: what is the role of imaging in diagnosis?|pdf=|usr=}}
| + | |
| − | {{tp|p=32321009|t=2020. COVID-19 pneumonia and the reversed halo sign |pdf=|usr=}}
| + | |
| − | {{tp|p=32294718|t=2020. Presentation of pulmonary infection on CT in COVID-19: initial experience in Brazil |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| − | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Respiration mgmt]]''' | + | *'''[[Case reports]]''' |
| − | {{tp|p=32251794|t=2020. Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?|pdf=|usr=}}
| + | |
| − | {{tp|p=32303885|t=ä. Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series |pdf=|usr=}}
| + | |
| − | {{tp|p=32337192|t=2020. COVID-19 Tragic Pandemic: Concerns over Unintentional ?Directed Accelerated Evolution? of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS |pdf=|usr=}}
| + | |
| − | {{tp|p=32361688|t=2020. Can glycopyrrolate come to the airway rescue in Covid-19 patients?|pdf=|usr=}} ''anti-sialogogue''
| + | |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32361701|t=2020. COVID-19 Rapid Guideline in Kidney Transplant Recipients |pdf=|usr=}}
| |
| − | {{tp|p=32378816|t=2020. Clinical Insights and Management Recommendations for COVID-19 Patients Hospitalized in Internal Medicine Departments: Recommendations by the Corona Department Heads in Israel |pdf=|usr=}}
| |
| − | {{tp|p=32278795|t=ä. Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease |pdf=|usr=}}
| |
| − | {{tp|p=32221153|t=2020. The looming pandemic of COVID-19: What therapeutic options do we have now?|pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Risk and special populations]]'''
| |
| − | {{tp|p=32370269|t=2020. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?|pdf=|usr=}}
| |
| − | {{tp|p=32244852|t=2020. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19) |pdf=|usr=}}
| |
| − |
| |
| − | *'''[[The morbid survivor]]'''
| |
| − | {{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − | *'''[[Case reports]]'''
| |
| − | {{tp|p=32269194|t=2020. Pneumonia Without Respiratory Symptoms |pdf=|usr=}}
| |
| − | {{tp|p=32361703|t=2020. Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32378815|t=2020. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32374474|t=2020. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells |pdf=|usr=}}
| |
| − | {{tp|p=32281268|t=2020. G6PD and chloroquine: Selecting the treatment against SARS?CoV?2?|pdf=|usr=}}
| |
| − | {{tp|p=32255648|t=ä. A Community Letter Regarding Sharing Biomolecular Simulation Data for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32315171|t=ä. Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study |pdf=|usr=}}
| |
| − | {{tp|p=32243270|t=2020. Potential therapeutic agents against COVID-19: What we know so far |pdf=|usr=}}
| |
| − | {{tp|p=32254064|t=2020. Deployment of convalescent plasma for the prevention and treatment of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32352407|t=2020. Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists |pdf=|usr=}}
| |
| − | {{tp|p=32167489|t=ä. The convalescent sera option for containing COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | ----
| + | *'''[[Other routes of infection]]''' |
| | | | |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Other routes of infection]]'''
| |
| − | {{tp|p=32335340|t=ä. Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health |pdf=|usr=}}
| |
| − | {{tp|p=32278800|t=ä. Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Passive protective equipment]]''' |
| | | | |
| − | *'''[[Remission, recurrence and persistence]]'''
| |
| − | {{tp|p=32200109|t=2020. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge |pdf=|usr=}}
| |
| − | {{tp|p=32251796|t=ä. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?|pdf=|usr=}}
| |
| − | {{tp|p=32147538|t=2020. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | *'''[[Passive protective equipment]]'''
| |
| − | {{tp|p=32278727|t=ä. Ethical Rationing of Personal Protective Equipment to Minimize Moral Residue During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32240303|t=ä. Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32353399|t=ä. Institution of a Novel Process for N95 Respirator Disinfection with Vaporized Hydrogen Peroxide in the setting of the COVID-19 Pandemic at a Large Academic Medical Center |pdf=|usr=}}
| |
| − | {{tp|p=32370924|t=ä. Personal Protective Equipment: Current Best Practices for Orthopaedic Teams |pdf=|usr=}}
| |
| − | {{tp|p=32354536|t=ä. Helmet Modification to PPE with 3D Printing During the COVID-19 Pandemic at Duke University Medical Center: A Novel Technique |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32303395|t=ä. Response and Operating Room Preparation for the COVID-19 Outbreak: A Perspective from the National Heart Centre Singapore |pdf=|usr=}}
| |
| − | {{tp|p=32279934|t=ä. Anesthesia Management and Perioperative Infection Control in Patients With the Novel Coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32268984|t=2020. Chinese Society of Anesthesiology Expert Consensus on Anesthetic Management of Cardiac Surgical Patients With Suspected or Confirmed Coronavirus Disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32220557|t=ä. Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Syndrome Coronavirus-2 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32360003|t=ä. Sometimes less is worse: an advise against non-intubated video-assisted thoracoscopy during COVID-19 pandemia |pdf=|usr=}}
| |
| − | {{tp|p=32362542|t=ä. Preventing Contamination During Transesophageal Echocardiography in the Face of the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32317235|t=ä. Society of Cardiovascular Computed Tomography Guidance for Use of Cardiac Computed Tomography Amidst the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32340614|t=2020. Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32304507|t=2020. Protecting against COVID-19 aerosol infection during intubation |pdf=|usr=}}
| |
| − | {{tp|p=32371331|t=2020. Strategies for daily operating room management of ambulatory surgery centers following resolution of the acute phase of the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32361284|t=2020. Chronic pain management in COVID-19 era |pdf=|usr=}}
| |
| − | {{tp|p=32361283|t=ä. Peripheral nerve blocks in a patient with suspected COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32362425|t=ä. COVID-19: General anesthesia precautions |pdf=|usr=}}
| |
| − | {{tp|p=32353808|t=2020. SARS-CoV-2 infection control measures for the anesthesiology department: experience from the Sichuan Provincial People s Hospital, China |pdf=|usr=}}
| |
| − | {{tp|p=32339809|t=ä. How to perform tracheal intubation for COVID-19 patients safely and effectively: Experience AND tips from Sichuan, China |pdf=|usr=}}
| |
| − | {{tp|p=32232480|t=2020. Our Response to COVID-19 as Endocrinologists and Diabetologists |pdf=|usr=}}
| |
| − | {{tp|p=32343810|t=ä. Letter to the Editor: Our Response to COVID-19 as Endocrinologists and Diabetologists |pdf=|usr=}}
| |
| − | {{tp|p=32315031|t=ä. Letter to the Editor: ?Our Response to COVID-19 as Endocrinologists and Diabetologists? |pdf=|usr=}}
| |
| − | {{tp|p=32310275|t=ä. Letter to the Editor: ?Our Response to COVID-19 as Endocrinologists and Diabetologists? |pdf=|usr=}}
| |
| − | {{tp|p=32250968|t=2020. Kidney diseases in the time of COVID-19: major challenges to patient care |pdf=|usr=}}
| |
| − | {{tp|p=32243259|t=2020. The COVID-19 pandemic and research shutdown: staying safe and productive |pdf=|usr=}}
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32259628|t=ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist |pdf=|usr=}}
| + | |
| − | {{tp|p=32208139|t=ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness |pdf=|usr=}}
| + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | | |
| | | | |
| | | | |
| − | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
| − | {{tp|p=32360185|t=ä. Exercise and Fitness in the age of social distancing during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32078967|t=2020. Coronaphobia: Fear and the 2019-nCoV outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32333185|t=ä. Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic |pdf=|usr=}}
| |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| | + | |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
| − | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 247: |
Zeile 145: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=32212099|t=ä. COVID-19 may transmit through aerosol |pdf=|usr=}}
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32332514|t=2020. Hospital visiting policies in the time of coronavirus disease 2019: A nationwide website survey in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32336471|t=2020. Methodological challenges in studying the COVID-19 pandemic crisis |pdf=|usr=}}
| |
| − | {{tp|p=32224550|t=2020. COVID-19 threatens health systems in sub-Saharan Africa: the eye of the crocodile |pdf=|usr=}}
| |
| − | {{tp|p=32369975|t=2020. Time from Symptom Onset to Hospitalisation of Coronavirus Disease 2019 (COVID-19) Cases: Implications for the Proportion of Transmissions from Infectors with Few Symptoms |pdf=|usr=}}
| |
| − | {{tp|p=32235480|t=2020. A Simulation on Potential Secondary Spread of Novel Coronavirus in an Exported Country Using a Stochastic Epidemic SEIR Model |pdf=|usr=}}
| |
| − | {{tp|p=32131537|t=2020. Optimization Method for Forecasting Confirmed Cases of COVID-19 in China |pdf=|usr=}}
| |
| − | {{tp|p=32183172|t=2020. Prediction of the Epidemic Peak of Coronavirus Disease in Japan, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=31991628|t=2020. The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32046137|t=2020. Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions |pdf=|usr=}}
| |
| − | {{tp|p=32033064|t=2020. The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights |pdf=|usr=}}
| |
| − | {{tp|p=32121356|t=2020. Backcalculating the Incidence of Infection with COVID-19 on the Diamond Princess |pdf=|usr=}}
| |
| − | {{tp|p=32102279|t=2020. Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32098289|t=2020. Short-term Forecasts of the COVID-19 Epidemic in Guangdong and Zhejiang, China: February 13?23, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32093211|t=2020. Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China |pdf=|usr=}}
| |
| − | {{tp|p=32093043|t=2020. Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China |pdf=|usr=}}
| |
| − | {{tp|p=32093043|t=2020. Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]''' | + | |
| | + | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
| + | |
| − | *[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
| + | |
| | | | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| |
| − |
| |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32343813|t=ä. Impact of the digital divide in the age of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32313877|t=ä. COVID-19 Epidemic and Enhancing China?s National Biosecurity System |pdf=|usr=}}
| + | |
| − | {{tp|p=32282413|t=ä. What?s Important: What Is Our Role in the COVID-19 Pandemic?|pdf=|usr=}}
| + | |
| − | {{tp|p=32134861|t=2020. The outbreak of COVID-19: An overview |pdf=|usr=}}
| + | |
| − | {{tp|p=32360509|t=ä. What evidence-based medicine researchers can do to help clinicians fighting COVID-2019?|pdf=|usr=}}
| + | |
| − | {{tp|p=32330521|t=ä. COVID-19 research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine |pdf=|usr=}}
| + | |
| − | {{tp|p=32325222|t=ä. Reply to letter to the editor ?Lessons from COVID-19 to Future Evidence Synthesis Efforts: First Living Search Strategy and Out of Date Scientific Publishing and Indexing Industry |pdf=|usr=}}
| + | |
| − | {{tp|p=32330122|t=2020. Panic prescribing has become omnipresent during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32244415|t=2020. People with Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health Literacy |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| + | |
| − | *[biomol.com assays cytokines general spectrum]
| + | |
| − | *
| + | |
| − | TAO technical wear masken die recht rational aussehen
| + | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
